Scrip Regulatory Affairs
French bill's approval means more sales taxes and price cuts for pharma in 2012
30 November 2011
Ian Schofield
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- France dilutes comparative trial demand, axes class actions as reform bill proceeds
- French MPs OK bill raising industry levy and imposing price cuts
- French senate OKs financing bill with wider promotional tax for pharma and new fund for regulatory body
- France votes for more regulatory transparency, tighter safety monitoring and tougher promotion controls
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
